We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+5.02%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$1.05B
AUM Growth
+$9.85M
Cap. Flow
+$95.1M
Cap. Flow %
9.1%
Top 10 Hldgs %
50%
Holding
874
New
223
Increased
214
Reduced
73
Closed
220

Top Buys

Rank Stock Value
1
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$54.9M
2
IMCR icon
Immunocore
IMCR
+$48.2M
3
ARKK icon
ARK Innovation ETF
ARKK
+$41.6M
4
TWTR
Twitter, Inc.
TWTR
+$36.7M
5
RNAM
Avidity Biosciences
RNAM
+$29.2M

Top Sells

Rank Stock Value
1
RLMD icon
Relmada Therapeutics
RLMD
+$23.6M
2
PSTH
Pershing Square Tontine Holdings, Ltd.
PSTH
+$19M
3
RBAC
RedBall Acquisition Corp.
RBAC
+$12.5M
4
SMFG icon
Sumitomo Mitsui Financial
SMFG
+$12.1M
5
STOK icon
Stoke Therapeutics
STOK
+$11.8M

Sector Composition

Rank Sector Weight
1 Healthcare 34.11%
2 Financials 8.03%
3 Materials 6.97%
4 Technology 3.58%
5 Industrials 3.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MACC.WS
426
DELISTED
Mission Advancement Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
MACC.WS
$9K ﹤0.01%
302,576
+101,566
+51% +$7.9K
AFARW
427
DELISTED
Aura FAT Projects Acquisition Corp Warrant
AFARW
$9K ﹤0.01%
229,930
+2,000
+0.9% +$153
PPHPR
428
DELISTED
PHP Ventures Acquisition Corp. Rights
PPHPR
$9K ﹤0.01%
200,551
– –
PSFE.WS
429
DELISTED
Paysafe Ltd Warrants
PSFE.WS
$8K ﹤0.01%
+50,000
New +$11.3K
SCLXW icon
430
Scilex Holding Co Warrant
SCLXW
$8K ﹤0.01%
49,596
-15,929
-24% -$3K
BNAIW
431
Brand Engagement Network Warrant
BNAIW
$2.14M
$8K ﹤0.01%
81,735
+70,735
+643% +$11.7K
PROCW
432
DELISTED
Procaps Group, S.A. Warrants
PROCW
$8K ﹤0.01%
10,000
– –
PPYAW
433
DELISTED
Papaya Growth Opportunity Corp. I Warrant
PPYAW
$8K ﹤0.01%
90,351
+1,851
+2% +$207
FRLAW
434
DELISTED
Fortune Rise Acquisition Corporation Warrant
FRLAW
$8K ﹤0.01%
138,640
+400
+0.3% +$35
BREZR
435
DELISTED
Breeze Holdings Acquisition Corp. Right
BREZR
$8K ﹤0.01%
+188,959
New +$14K
SLACW
436
DELISTED
Social Leverage Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SLACW
$8K ﹤0.01%
35,088
-63,730
-64% -$20.4K
KNSW.WS
437
DELISTED
KnightSwan Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
KNSW.WS
$8K ﹤0.01%
79,582
– –
FGMCW
438
DELISTED
FG Merger Corp. Warrant
FGMCW
$8K ﹤0.01%
50,000
– –
PNACW
439
DELISTED
Prime Number Acquisition I Corp. Warrant
PNACW
$8K ﹤0.01%
+164,741
New +$10.1K
TWCBW
440
DELISTED
Bilander Acquisition Corp. Warrant
TWCBW
$8K ﹤0.01%
39,124
+424
+1% +$111
NHICW
441
DELISTED
NewHold Investment Corp. II Warrant
NHICW
$8K ﹤0.01%
91,605
-200
-0.2% -$39
REVEW
442
DELISTED
Alpine Acquisition Corp Warrant
REVEW
$8K ﹤0.01%
57,489
+700
+1% +$95
CLAA.WS
443
DELISTED
Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
CLAA.WS
$8K ﹤0.01%
+67,757
New +$9.34K
NVSAW
444
DELISTED
New Vista Acquisition Corp. Warrant
NVSAW
$8K ﹤0.01%
+108,333
New +$11.7K
SCMAW
445
DELISTED
Seaport Calibre Materials Acquisition Corp. Warrant
SCMAW
$8K ﹤0.01%
76,100
– –
AXH.WS
446
DELISTED
Industrial Human Capital, Inc. Warrants
AXH.WS
$8K ﹤0.01%
423,841
-200
-0% -$5
ESSCR
447
DELISTED
East Stone Acquisition Corporation Right
ESSCR
$8K ﹤0.01%
30,000
– –
BRD.WS
448
DELISTED
Beard Energy Transition Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
BRD.WS
$8K ﹤0.01%
+83,311
New +$13K
AMLX icon
449
Amylyx Pharmaceuticals
AMLX
$2.63B
$7K ﹤0.01%
+20,800
New +$519K
ICUCW
450
SeaStar Medical Holding Corp Warrant
ICUCW
$331K
$7K ﹤0.01%
92,700
– –
16 17
18
19 20

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q3 2022 Portfolio in Review

As of Q3 2022, Cowen and Company held 874 positions worth $1.05B, up 0.95% from $1.04B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Cowen and Company deployed $95.1M of net new capital in Q3 2022, opening 223 new positions and adding to 214 existing holdings. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 726,608 shares worth $20.8M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 29% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Relmada Therapeutics, an estimated $23.6M trimmed.

  • Cowen and Company's largest Q3 2022 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 726,608 shares worth $20.8M.
  • Cowen and Company added most to ARK Innovation ETF in Q3 2022, an estimated $41.6M increase.
  • Cowen and Company's biggest Q3 2022 reduction was Relmada Therapeutics, cutting an estimated $23.6M.
  • Cowen and Company fully exited Pershing Square Tontine Holdings, Ltd. in Q3 2022, selling an estimated $19M.
  • Cowen and Company's ten largest holdings make up 50% of its $1.05B portfolio in Q3 2022.
  • Cowen and Company opened 223 new positions and closed 220 in Q3 2022.
  • Cowen and Company's portfolio value rose 0.95% quarter-over-quarter to $1.05B.

Based on Cowen and Company's 13F filing for Q3 2022, filed 14 Nov 2022.